Shanghai Yizhong Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 688091.SS

Shanghai Yizhong Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2023: USD 221.61 M

Shanghai Yizhong Pharmaceutical Co., Ltd. Total Assets is USD 221.61 M for the year ending December 31, 2023, a 12.90% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Shanghai Yizhong Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 196.29 M, a 3.89% change year over year.
Shanghai Yizhong Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 188.94 M, a 376.53% change year over year.
Shanghai Yizhong Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 39.65 M, a -0.54% change year over year.
Shanghai Yizhong Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 39.87 M, a 19.56% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shanghai Stock Exchange: 688091.SS

Shanghai Yizhong Pharmaceutical Co., Ltd.

CEO	Mr. Jingsong Zhou
IPO Date	Sept. 9, 2021
Location	China
Headquarters	No.79 Renqi Road
Employees	304
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. The company was founded in 2009 and is based in Shanghai, China.

Key trends

Past 5 years